About Docuvera
Created for Pharma. Built for What's Next.
Docuvera is a leading software company specializing in AI-powered structured content authoring solutions for the pharmaceutical and life sciences industries. Our governance platform enables organizations to streamline the creation, review, approval, translation, and publication of regulated documents by reusing approved, compliant component content.
By integrating structured component authoring—traditional writing and first draft creation using GenAI, metadata governance, content reuse, and validation-ready configurations—Docuvera enables teams to create once and confidently reuse across products, markets, and functions.
This capability forms a foundational layer of digital transformation in pharma, turning content into governed, structured data that can scale globally, align with automation initiatives, and adapt to regulatory change.



Our Origins
Founded in 1996 as part of Author-it Software Corporation, a pioneer in component content management, Docuvera emerged in 2017 as a purpose-built platform addressing the increasing complexity of pharmaceutical documentation and evolving regulatory requirements. Now operating as an independent entity, Docuvera is dedicated exclusively to serving the pharmaceutical and life sciences sectors.
Empowering Life Sciences with Intelligent Content Management
Docuvera sets itself apart in two ways that are essential for today’s pharmaceutical organizations. First, our approach to structured content authoring works at the component level to enable precise reuse, automation, and regulatory clarity at scale.
Second, we enable a truly governance-first, content-centric strategy, moving beyond document-based systems to help teams manage and deliver modular, approved content across regions, functions, and use cases. These two capabilities work together to reduce complexity, improve consistency, and accelerate time-to-market in an increasingly demanding regulatory environment.
Trusted by Industry Leaders
Global pharmaceutical companies, including Eli Lilly and Boehringer Ingelheim, have adopted Docuvera to enhance their documentation processes. Eli Lilly, for instance, has achieved more than 80% reuse in production today.




More Than Technology. A Strategic Solution.
In May 2025, Docuvera joined Bertelsmann Investments’ company, cormeo, which aims to streamline the “smart information lifecycle” for pharmaceutical companies, regulatory bodies, healthcare professionals, and patients. This acquisition underscores our long term commitment to delivering cutting-edge solutions that meet the evolving needs of the life sciences sector.
Leading organizations select Docuvera for more than software—they rely on our domain experience, implementation discipline, and long-term partnership model to drive sustainable results.
People First. Customer-Centric Principles that Guide Our Work

Meet the Leadership Team Behind Docuvera

Steve Owens
Chief Executive Officer
Leads strategy and operations. Brings enterprise SaaS leadership and a record of guiding high-growth organizations through scale and change.

Edwin Read
Chief Financial Officer
Oversees financial strategy and governance. Supports responsible growth and long-term investment capacity.

Murali Menon
Chief Revenue Officer
Leads sales, customer-facing services and implementation delivery, aligning Docuvera solutions with real-world business needs.

Jaco van Wyk
Chief Technology Officer
Brings over 30 years of experience in secure, scalable software architecture for regulated industries.

Donna Fritz
Chief Marketing Officer
Directs brand and growth strategy. Deep expertise in life sciences, B2B SaaS, and digital transformation communications.

Elizabeth O’Brien
Head of People
Leads people strategy, talent development, and organizational culture across a global, hybrid team.

Kendra Jones
Vice President, Implementation
Leads customer onboarding, implementation, success, and support.

Kenneth Gutierrez
Director, Product
Drives product strategy and roadmap development, guided by customer feedback and evolving regulatory trends.
Our Mission: Structured Content as a Strategic Advantage
Built for Pharma
Docuvera helps pharmaceutical companies reimagine how regulated content is created, managed, and maintained—turning documentation into a source of competitive agility, not operational friction.
Structured for Compliance
We believe structured content is a key driver of digital transformation in pharma. It enables faster submissions, global content reuse, version control at scale, and seamless alignment with regulatory frameworks.
Designed to Enable
We’re not a tool. We enable a better, and more future-proof way of working.
Careers at Docuvera
We’re always looking for curious, capable professionals who are passionate about solving meaningful problems in life sciences. If you’re interested in helping transform how the world’s top pharmaceutical companies manage regulated content, we encourage you to learn more.
Start the Conversation
If your organization is evolving its approach to regulatory content, modular authoring, or digital transformation in documentation—we’re ready to help.